Novo Nordisk’s weight loss and diabetes medication semaglutide, the active ingredient in both Wegovy and Ozempic, has been shown to improve symptoms associated with the most common form of heart failure, adding to its list of potential benefits.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.